Literature DB >> 32367057

Elevated sorbitol underlies a heritable neuropathy.

Eva Morava1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32367057     DOI: 10.1038/s41588-020-0619-0

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  2 in total

1.  Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes.

Authors:  Andrea Cortese; Yi Zhu; Adriana P Rebelo; Sara Negri; Steve Courel; Lisa Abreu; Chelsea J Bacon; Yunhong Bai; Dana M Bis-Brewer; Enrico Bugiardini; Elena Buglo; Matt C Danzi; Shawna M E Feely; Alkyoni Athanasiou-Fragkouli; Nourelhoda A Haridy; Rosario Isasi; Alaa Khan; Matilde Laurà; Stefania Magri; Menelaos Pipis; Chiara Pisciotta; Eric Powell; Alexander M Rossor; Paola Saveri; Janet E Sowden; Stefano Tozza; Jana Vandrovcova; Julia Dallman; Elena Grignani; Enrico Marchioni; Steven S Scherer; Beisha Tang; Zhiqiang Lin; Abdullah Al-Ajmi; Rebecca Schüle; Matthis Synofzik; Thierry Maisonobe; Tanya Stojkovic; Michaela Auer-Grumbach; Mohamed A Abdelhamed; Sherifa A Hamed; Ruxu Zhang; Fiore Manganelli; Lucio Santoro; Franco Taroni; Davide Pareyson; Henry Houlden; David N Herrmann; Mary M Reilly; Michael E Shy; R Grace Zhai; Stephan Zuchner
Journal:  Nat Genet       Date:  2020-05-04       Impact factor: 41.307

2.  Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats.

Authors:  Lixia Ji; Lixia Cheng; Zhihong Yang
Journal:  J Diabetes Res       Date:  2017-09-05       Impact factor: 4.011

  2 in total
  1 in total

Review 1.  Development of Novel Indole-Based Bifunctional Aldose Reductase Inhibitors/Antioxidants as Promising Drugs for the Treatment of Diabetic Complications.

Authors:  Lucia Kovacikova; Marta Soltesova Prnova; Magdalena Majekova; Andrej Bohac; Cimen Karasu; Milan Stefek
Journal:  Molecules       Date:  2021-05-12       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.